✦ LIBER ✦

Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study

✍ Scribed by M. Amore; M. Bertelli; D. Villani; S. Tamborini; M. Rossi

Book ID: 114741405
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 181 KB
Volume: 55
Category: Article
ISSN: 0964-2633
DOI: 10.1111/j.1365-2788.2010.01352.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Olanzapine for chronic, stereotypic self

Olanzapine for chronic, stereotypic self-injurious behaviour: a pilot study in seven adults with intellectual disability

✍ M. McDonough; J. Hillery; N. Kennedy 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Risperidone, haloperidol, and placebo in

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial

✍ Peter Tyrer; Patricia C Oliver-Africano; Zed Ahmed; Nick Bouras; Sherva Cooray; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 143 KB

Overcoming the barriers experienced in c

Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities

✍ P. Oliver-Africano; S. Dickens; Z. Ahmed; N. Bouras; S. Cooray; S. Deb; M. Knapp 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Effect of divalproex sodium on aggressio

Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability: a retrospective review

✍ S. Ruedrich; T. P. Swales; C. Fossaceca; J. Toliver; A. Rutkowski 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Reduced short-term obsessive–compulsive

Reduced short-term obsessive–compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study

✍ Baybars Veznedaroglu; Eyup Sabri Ercan; Bulent Kayahan; Azmi Varan; Erhan Bayrak 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract ## Background Risperidone is a widely used agent as first‐line treatment in schizophrenia with a favorable side‐effect profile. However, a number of case reports have suggested an increase in obsessive–compulsive symptoms in patients treated with risperidone. ## Objective The aim of

An Open-Label Study of Risperidone in th

An Open-Label Study of Risperidone in the Improvement of Quality of Life and Treatment of Symptoms of Violent and Self-Injurious Behaviour in Adults with Intellectual Disability

✍ Stephen G. Read; Maureen Rendall 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB